Verapamil Withdrawn Phase 1 Trials for Stroke, Ischemic Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02823106Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response